Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

US, Canada and Australia simultaneously fast-track Keytruda/Lenvima combo for endometrial cancer

September 18, 2019 Research and Development, Sales and Marketing Australian Therapeutic Goods Administration, Cancer, FDA, Health Canada, Lenvima, keytruda, pharma

The FDA has acted under a new initiative in collaboration with the Australian Therapeutic Goods Administration (TGA) and Health Canada, …
News

UKRI Chief Executive Sir Mark Walport to step down in 2020

September 17, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing UKRI, appointment, pharma

Sir Mark Walport, Chief Executive of UK Research and Innovation (UKRI), the national funding agency responsible for science and research …
Appointment
jerome-carle-general-manager-of-julphar-photo-aetos-wire

Jerome Carle steps down as Julphar Chief Executive

September 16, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Chief Executive of Gulf Pharmaceutical Industries, Jerome Carle, is stepping down from his post at the United Arab Emirates drug …
Appointment
lung_ambition_alliance

Breaking through limits in lung cancer: Introducing The Lung Ambition Alliance

September 16, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Cancer, Lung Ambition Alliance, lung cancer, oncology, pharma

Patrick Connor, VP and Global Franchise Head, Tumor Drivers and Resistance Mechanisms, at AstraZeneca, discusses his company’s role in the …
Feature
OxyContin

Opioid drugmaker Purdue Pharma files for bankruptcy

September 16, 2019 Sales and Marketing OxyContin, Purdue Pharma

In the face of thousands of lawsuits in its role in the opioid addiction crisis, Purdue Pharma   announced yesterday that …
News
peanuts_nuts_snack_nutrition_healthy_nibble_decoration_close-842313

Aimmune’s peanut allergy therapy recommended for approval by FDA committee

September 16, 2019 Sales and Marketing Aimmune, FDA, peanut allergy, pharma

The FDA’s Allergenic Products Advisory Committee (APAC) has recommended the use of Aimmune Therapeutics’ AR101, also known by its proposed …
News

Lundbeck acquires Alder in $2bn migraine treatment move

September 16, 2019 Sales and Marketing Alder, Lundbeck, eptinezumab, migraine

Lundbeck is to buy Alder Biopharmaceuticals for $2 billion enhancing its leading portfolio of brain disease therapies through the acquisition …
News
amgen_flag

Amgen’s Kyprolis + Darzalex combo shows progression-free survival benefit in multiple myeloma

September 16, 2019 Research and Development, Sales and Marketing Amgen, Kyrpolis, darzalex, multiple myeloma, pharma

Amgen has revealed new Phase 3 data for the combination of Kyprolis (carfilzomib) and Darzalex (daratumumab) in addition to the …
News

Novartis announce robust Phase 3 trials for ofatumumab in MS

September 16, 2019 Research and Development, Sales and Marketing Aubagio, Novartis, multiple sclerosis

Novartis’ multiple sclerosis candidate has demonstrated strong results in its Phase 3 ASCLEPIOS trials meeting primary endpoints and slashing the …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

September 13, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

It’s Friday again and time for another rundown of the top most popular articles on Pharmafile.com this week. This past …
News

UKRI Chief Executive Sir Mark Walport to step down in 2020

September 13, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing UKRI, appointment, pharma

Sir Mark Walport, Chief Executive of UK Research and Innovation (UKRI), the national funding agency responsible for science and research …
News
vertex-headquarters

Vertex cystic fibrosis drugs become available in Scotland after NHS rejection

September 12, 2019 Sales and Marketing SMC, Vertex, cystic fibrosis

Two potentially life-changing cystic fibrosis drugs are to become available for a potential pool of 400 patients in Scotland just …
News
pharmafocus_sept_2019_cover

Read the September edition of Pharmafocus online now!

September 12, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, brexit, lung cancer, medicinal cannabis, pharma

The latest monthly edition of Pharmafocus, the September issue, is available to read for free online now!With a new Prime …
News
stephen_stamp

Former Ergomed CEO appointed as Midatech’s Chief Financial Officer

September 11, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ergomed, midatech

Immunotherapy-focused pharmaceutical company Midatech Pharma has appointed Stephen Stamp as Chief Financial Officer (CFO) with immediate effect. He will be …
Appointment

GlaxoSmithKline acquires Sitari Pharmaceuticals after progress in coeliac disease

September 11, 2019 Research and Development, Sales and Marketing Avalon Ventures, GSK, coeliac disease

Avalon Ventures has announced that it has entered into a definitive agreement with GSK for the acquisition of Sitari Pharmaceuticals …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026